Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

BACKGROUND: The use of DTG-containing two-drug regimens is one of the most promising solutions to the need to ease the management of HIV treatment without harming its efficacy and safety. We report long- term results in patients switched, while virologically suppressed, to the combination of doluteg...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggiolo, Franco, Gulminetti, Roberto, Pagnucco, Layla, Digaetano, Margherita, Cervo, Adriana, Valenti, Daniela, Callegaro, Annapaola, Mussini, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558382/
https://www.ncbi.nlm.nih.gov/pubmed/36224538
http://dx.doi.org/10.1186/s12879-022-07769-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558382/
https://www.ncbi.nlm.nih.gov/pubmed/36224538
http://dx.doi.org/10.1186/s12879-022-07769-6

Ejemplares similares